When the healthcare world needs answers, Elion asks the right questions.
$9.3M worth of the right questions, to be exact. That’s the size of the latest oversubscribed seed round, led by NEA’s Michael Li, with fresh conviction from Cedars Sinai Health Ventures (Maureen Burgess and Rohit Rajkumar), TMV (Emma Silverman and Soraya Darabi), Scrub Capital (Christina Farr, Dr. Rebecca Mitchell, and Dr. Jonathan Slotkin), and Alumni Ventures. The repeat believers, Max Ventures, AlleyCorp, Floating Point, and Riverside Ventures, came back to the table, not out of nostalgia, but because Elion isn’t just building a company. They’re building clarity in a market drowning in noise.
Let’s rewind. Bobby Guelich walked through Oscar Health and TrialSpark with one hand on operations and the other sorting through a spaghetti mess of vendors that all sounded the same, promised the same, and delivered, let’s call it “inconsistent enlightenment.” Matthew Weinberg saw the same mess from the VC side at Max Ventures. And Lily Huang brought the pattern-matching precision of NEA to the table. Same pain, different angles. So the trio teamed up, not to admire the problem, but to Elionate it.
Today, Elion is the intelligence layer sitting above the chaos of healthcare tech. 60% of U.S. health systems are already tapping in. Over 1,500 products across 125+ categories, from clinical tools to AI copilots, are mapped, dissected, and stacked inside a platform that doesn’t just search; it understands. The fivefold usage growth over the past year isn’t because people like shiny tools, it’s because procurement folks are tired of choosing software with less context than a dating app bio.
This isn’t just a vendor marketplace. It’s what happens when research, context, and structured intelligence meet velocity. Patrick Wingo and the research team are out here writing the AI bible for health IT, publishing landmark reports like AI Clinician Copilots and the State of AI in RCM 2024 that help execs cut through buzzwords and bias.
And they’re not stopping. With this new capital, Elion’s scaling its engineering, research, and go-to-market teams. Think deeper data. Sharper product. More ways to help healthcare builders build smarter, faster, and with eyes wide open.
There’s a reason the Coalition for Health AI is embedding its model cards right inside Elion’s platform. Transparency, meet distribution.
So if you’re still making vendor decisions by spreadsheet, email thread, or vibes, you’re playing checkers in a chess game. Elion’s already past opening theory. Congratulations to CEO Bobby Guelich and co-founder Matthew Weinberg. Welcome to round two. Healthcare’s most trusted intelligence platform just got smarter.
